BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
rs6983267
,
FXYD4
,
Metabolism of xenobiotics
,
Ischemia
,
Retina
,
Vitamin E
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
Cyclin-dependent kinase inhibitor
(biogroup)
Summary
General Info
Body Atlas
Most Correlated Tissues
Salivary gland
Liver
Peritoneum
Pericardium
Testes
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Carditis
Perforation of tympanic membrane
Vesicular stomatitis Indiana virus disease
Umbilical hernia
Myocardial ischemia
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
RPI-1 cpd
Aflatoxins
Triamcinolone Acetonide
Ficoll
Zalypsis
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
Idd1
Idd5
CYP4Z2P
NLGN1
TIA1
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
Peripheral blood of patients afflicted with infective endocarditis
Drug Matrix In Vivo Toxicogenomic Study - Rat Kidney [Codelink]
L1000 CMAP Prostate cancer PC3 cells with gene overexpression perturbations (2 of 2)
NSCLC PC9 cells selected for gefitinib sensitivity or resistance treated with EGF and gefitinib
L1000 CMAP - Amelanotic malignant melanoma of skin A375 cells treated with ligand perturbagens
Explore Curated Studies Results
Literature
Most Relevant Literature
There were no matches for Cyclin-dependent kinase inhibitor
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
A Study Of Oral Palbociclib (PD-0332991), A Cyclin-Dependent Kinase Inhibitor, In Patients With Adva…
Evaluation of Skin Health and Quality of Life in Patients Receiving Anti-PD1/PDL1/CTLA4 or Cyclin-de…
A Phase 1 Study Of An Intravenously Administered Cyclin-Dependent Kinase Inhibitor In Patients With …
Pilot Study Assessing the Effect of Cyclin-dependent Kinase 4/6 Inhibitors on Body Composition in Pa…
A Pharmacologic Study of CYC065, a Cyclin Dependent Kinase Inhibitor, in Patients With Advanced Canc…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ